116 related articles for article (PubMed ID: 16791262)
1. Hyperforin, a new lead compound against the progression of cancer and leukemia?
Quiney C; Billard C; Salanoubat C; Fourneron JD; Kolb JP
Leukemia; 2006 Sep; 20(9):1519-25. PubMed ID: 16791262
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin: more than an antidepressant bioactive compound?
Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
[TBL] [Abstract][Full Text] [Related]
3. Cellular neurobiology of hyperforin.
Bouron A
Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
[TBL] [Abstract][Full Text] [Related]
4. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
5. Role of hyperforin in the pharmacological activities of St. John's Wort.
Zanoli P
CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
7. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
[TBL] [Abstract][Full Text] [Related]
8. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
9. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into the antileukemic activity of hyperforin.
Billard C; Merhi F; Bauvois B
Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
[TBL] [Abstract][Full Text] [Related]
12. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
[TBL] [Abstract][Full Text] [Related]
13. Hyperforin: A natural lead compound with multiple pharmacological activities.
Li XX; Yan Y; Zhang J; Ding K; Xia CY; Pan XG; Shi YJ; Xu JK; He J; Zhang WK
Phytochemistry; 2023 Feb; 206():113526. PubMed ID: 36442576
[TBL] [Abstract][Full Text] [Related]
14. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
Martínez-Poveda B; Quesada AR; Medina MA
Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
[TBL] [Abstract][Full Text] [Related]
16. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
[TBL] [Abstract][Full Text] [Related]
17. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
18. Hyperforin.
Beerhues L
Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
[TBL] [Abstract][Full Text] [Related]
19. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
Kraus B; Wolff H; Elstner EF; Heilmann J
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
[TBL] [Abstract][Full Text] [Related]
20. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
Weber CC; Kressmann S; Fricker G; Müller WE
Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
